1. Home
  2. PDYN vs TTRX Comparison

PDYN vs TTRX Comparison

Compare PDYN & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palladyne AI Corp.

PDYN

Palladyne AI Corp.

HOLD

Current Price

$5.30

Market Cap

287.2M

Sector

Industrials

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$9.44

Market Cap

281.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDYN
TTRX
Founded
1983
2015
Country
United States
United States
Employees
70
2
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
287.2M
281.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PDYN
TTRX
Price
$5.30
$9.44
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$9.67
$8.00
AVG Volume (30 Days)
2.3M
86.0K
Earning Date
05-05-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$384.48
N/A
Revenue Next Year
$63.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.14
$2.57
52 Week High
$12.79
$11.69

Technical Indicators

Market Signals
Indicator
PDYN
TTRX
Relative Strength Index (RSI) 37.35 72.73
Support Level $5.04 $4.40
Resistance Level $6.71 N/A
Average True Range (ATR) 0.48 0.99
MACD -0.07 0.24
Stochastic Oscillator 4.38 63.82

Price Performance

Historical Comparison
PDYN
TTRX

About PDYN Palladyne AI Corp.

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: